Amgen Inc (NASDAQ:AMGN)
| 268.81 Delayed Data As of Sep 29 |  -2.01 / -0.74%Today’s Change | 211.71 Today|||52-Week Range 296.67 | +2.35% Year-to-Date |
Latest AMGN News | Press Releases
Today’s Trading
| Previous close | 270.82 |
| Today’s open | 270.51 |
| Day’s range | 267.22 - 270.68 |
| Volume | 110,686 |
| Average volume (3 months) | 2,572,395 |
| Market cap | $143.2B |
Data as of 4:00pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | +17.80% |
| Earnings growth (this year) | +0.50% |
| Earnings growth (next 5 years) | +4.50% |
| Revenue growth (last year) | +0.40% |
| P/E ratio | 18.1 |
| Price/Sales | 5.45 |
| Price/Book | 39.05 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | -0.45 | -0.60% |
| ---- | ||
| MRNAModerna Inc | +3.05 | +3.04% |
| BIIBBiogen | -0.82 | -0.32% |
Data as of 4:00pm ET, 09/29/2023
Financials
| Next reporting date | October 31, 2023 |
| EPS forecast (this quarter) | $4.74 |
| Annual revenue (last year) | $26.1B |
| Annual profit (last year) | $6.6B |
| Net profit margin | 25.11% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Thousand Oaks, California |
Forecasts
